WHO ICTRP trial
The Efficacy and Safety of Corticosteroids in Combination with Ruxolitinib and…
ChiCTR2400091860 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400091860 |
|---|---|
| Public title | The Efficacy and Safety of Corticosteroids in Combination with Ruxolitinib and Traditional Chinese Medicine in the Treatment of Severe Immune Checkpoint Inhibitor-Associated Myocarditis |
| Scientific title | Evidence-based Strategies for the Prevention and Management of Severe Immune Checkpoint Inhibitor-associated Myocarditis with Traditional Chinese Medicine(The Efficacy and Safety of Corticosteroids in Combination with Ruxolitinib and Traditional Chinese Medicine in the Treatment of Severe Immune… |
| Primary sponsor | Peking Union Medical College Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | immune checkpoint inhibitor-associated myocarditis |
| Interventions | Conventional treatment group:Glucocorticoids +/- immunosuppressive or biological agents;Conventional treatment + rucotinib treatment group:Conventional therapy + rucotinib;Conventional treatment + rucotinib + Chinese medicine treatment… |
| Registration date | Nov 5, 2024 |
| Target size | Conventional treatment group:27;Conventional treatment + rucotinib treatment… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: